4//SEC Filing
PDL BIOPHARMA, INC. 4
Accession 0000882104-17-000019
CIK 0000882104operating
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 8:18 PM ET
Size
4.9 KB
Accession
0000882104-17-000019
Insider Transaction Report
Form 4
Hart Danny J Jr.
Assoc Genl Counsel/Asst Sec
Transactions
- Award
Common stock
2017-03-04$2.04/sh+199,019$405,999→ 387,236 total
Footnotes (1)
- [F1]The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved, based upon the following schedule: 50% on December 2018; 16.66% on December 2019; 16.66% on December 2020; and 16.66% on December 2021.
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000882104
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 8:18 PM ET
- Size
- 4.9 KB